About Us

Alliance to Modernize Prescribing Information (AMPI)

AMPI (The Alliance) is a group of pharmaceutical stakeholders and environmental organizations with a common interest in advancing regulatory or legislative reforms to facilitate the dissemination of FDA-approved pharmaceutical labeling information via modern digital platforms.  The initiative advances a vision for FDA labeling that supports patient safety, informed physician and patient decision making, adds digital convenience, addresses health literacy, and reduces unnecessary waste from paper-based information for pharmaceuticals.

Our Mission

The Alliance brings together technical expertise, real world experience, regulatory knowledge, public policy understanding, and government affairs expertise to develop a consensus proposal for electronic approved labeling information and to develop and execute a strategy to implement that proposal. 

Membership

AbbVie
 
AmerisourceBergen
 
AstraZeneca
  
Bayer
 
Bristol Myers Squibb
Fresenius Kabi

Merck
 
Pfizer
 
Viatris

Supporters

Academy of Managed Care Pharmacy (AMCP)
 
Allergy & Asthma Network
 
American Pharmacists Association
 
AmGen
 
Asthma and Allergy Foundation of America
 
Association for Accessible Medicines
 
Beyond Type 1
 
Biotechnology Innovation Organization
 
BioNJ
 
BioUtah
 
Boomer Esiason Foundation
 
Eli Lilly and Company
 
Environmental Paper Network
 
Georgia Bio
Healthcare Distribution Alliance
 
HealthCare Institute of New Jersey
 
LUNGevity Foundation
 
Lupin
 
Maryland Tech Council
 
MassBio
 
McKesson
 
National Association of Chain Drug Stores
 
National Consumers League
 
National Grange
 
NewYorkBIO
 
North Carolina Biosciences Organization
 
Texas Healthcare and Biosciences Institute
 
Zero Cancer